St. Johns Investment Management Company, LLC Abbott Laboratories Transaction History

St. Johns Investment Management Company, LLC

  • $215 Million
  • Q4 2024

A detailed history of St. Johns Investment Management Company, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, St. Johns Investment Management Company, LLC holds 10,771 shares of ABT stock, worth $1.38 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
10,771
Previous 11,061 2.62%
Holding current value
$1.38 Million
Previous $1.26 Million 3.41%
% of portfolio
0.57%
Previous 0.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$111.93 - $119.39 $32,459 - $34,623
-290 Reduced 2.62%
10,771 $1.22 Million
Q3 2024

Oct 23, 2024
BUY
$100.07 - $118.13 $53,737 - $63,435
537 Added 5.1%
11,061 $1.26 Million
Q2 2024

Jul 25, 2024
SELL
$100.73 - $112.44 $12,188 - $13,605
-121 Reduced 1.14%
10,524 $1.09 Million
Q1 2024

Apr 15, 2024
SELL
$109.52 - $120.96 $118,391 - $130,757
-1,081 Reduced 9.22%
10,645 $1.21 Million
Q4 2023

Feb 07, 2024
SELL
$90.19 - $110.4 $23,990 - $29,366
-266 Reduced 2.22%
11,726 $1.29 Million
Q3 2023

Oct 13, 2023
SELL
$95.53 - $114.62 $27,226 - $32,666
-285 Reduced 2.32%
11,992 $1.16 Million
Q2 2023

Jul 20, 2023
SELL
$100.78 - $112.29 $74,577 - $83,094
-740 Reduced 5.68%
12,277 $1.34 Million
Q1 2023

May 04, 2023
SELL
$96.86 - $114.01 $138,606 - $163,148
-1,431 Reduced 9.9%
13,017 $1.32 Million
Q4 2022

Feb 10, 2023
SELL
$95.06 - $111.52 $29,468 - $34,571
-310 Reduced 2.1%
14,448 $1.59 Million
Q3 2022

Nov 02, 2022
SELL
$96.76 - $112.03 $7,837 - $9,074
-81 Reduced 0.55%
14,758 $1.43 Million
Q2 2022

Aug 03, 2022
SELL
$102.07 - $123.37 $61,446 - $74,268
-602 Reduced 3.9%
14,839 $1.61 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $59,404 - $72,439
-521 Reduced 3.26%
15,441 $1.83 Million
Q4 2021

Feb 08, 2022
SELL
$115.53 - $141.46 $28,535 - $34,940
-247 Reduced 1.52%
15,962 $2.25 Million
Q3 2021

Nov 04, 2021
SELL
$116.66 - $129.06 $40,131 - $44,396
-344 Reduced 2.08%
16,209 $1.92 Million
Q2 2021

Aug 04, 2021
BUY
$105.79 - $124.53 $5,289 - $6,226
50 Added 0.3%
16,553 $1.92 Million
Q1 2021

Apr 30, 2021
SELL
$108.84 - $128.23 $13,496 - $15,900
-124 Reduced 0.75%
16,503 $1.98 Million
Q4 2020

Feb 05, 2021
SELL
$105.0 - $114.42 $28,980 - $31,579
-276 Reduced 1.63%
16,627 $1.82 Million
Q3 2020

Oct 23, 2020
SELL
$91.64 - $111.29 $9,347 - $11,351
-102 Reduced 0.6%
16,903 $1.84 Million
Q2 2020

Jul 27, 2020
SELL
$76.57 - $98.0 $40,199 - $51,450
-525 Reduced 2.99%
17,005 $1.56 Million
Q1 2020

Apr 27, 2020
SELL
$62.82 - $91.86 $29,713 - $43,449
-473 Reduced 2.63%
17,530 $1.38 Million
Q4 2019

Jan 30, 2020
SELL
$78.51 - $87.4 $75,683 - $84,253
-964 Reduced 5.08%
18,003 $1.56 Million
Q3 2019

Oct 21, 2019
SELL
$81.84 - $88.74 $3,846 - $4,170
-47 Reduced 0.25%
18,967 $1.59 Million
Q2 2019

Jul 24, 2019
BUY
$72.88 - $85.0 $9,547 - $11,135
131 Added 0.69%
19,014 $1.6 Million
Q1 2019

Apr 17, 2019
SELL
$66.22 - $80.06 $10,528 - $12,729
-159 Reduced 0.83%
18,883 $1.51 Million
Q4 2018

Feb 05, 2019
BUY
$65.56 - $74.27 $14,423 - $16,339
220 Added 1.17%
19,042 $1.38 Million
Q3 2018

Oct 22, 2018
SELL
$60.81 - $73.36 $91,762 - $110,700
-1,509 Reduced 7.42%
18,822 $1.38 Million
Q2 2018

Jul 18, 2018
SELL
$57.57 - $63.54 $17,558 - $19,379
-305 Reduced 1.48%
20,331 $1.24 Million
Q1 2018

May 03, 2018
BUY
$56.27 - $63.62 $5,233 - $5,916
93 Added 0.45%
20,636 $1.24 Million
Q4 2017

Jan 16, 2018
SELL
$53.68 - $57.47 $15,030 - $16,091
-280 Reduced 1.34%
20,543 $1.17 Million
Q3 2017

Oct 17, 2017
BUY
$48.06 - $53.64 $1 Million - $1.12 Million
20,823
20,823 $1.11 Million

Others Institutions Holding ABT

# of Institutions
3,224
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track St. Johns Investment Management Company, LLC Portfolio

Follow St. Johns Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Johns Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Johns Investment Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email